Strong Financial Performance
Ordinary net profit increased by 17% to EUR 392 million, and on a reported basis, net profit stood at EUR 450 million. Sales and EBITDA were up by 28.6% and 23.9%, respectively.
Robust Order Backlog
Order backlog grew by 12% FX adjusted to EUR 89.3 billion, with new orders reaching EUR 31.7 billion, up 18.1% FX adjusted.
Turner's Outstanding Performance
Turner's contribution to net profit rose by 64% to EUR 227 million, driven by strong growth in high-tech markets and biopharma.
Strong Cash Flow Generation
Net operating cash flow adjusted for factoring variations reached EUR 1.8 billion, up EUR 265 million year-on-year.
Strategic Investments
EUR 1.1 billion allocated to strategic investments, including EUR 436 million acquisition of Dornan and EUR 476 million in net equity investments.